Brief: Valbiotis Announces First Preclinical Data On Metformin + Totum-63 Combination For Diabetes

Valbiotis SA

04/12/2017 16:38

Dec 4 (Reuters) - VALBIOTIS SAS  ALVAL.PA : 
    * ANNOUNCES FIRST PRECLINICAL DATA ON METFORMIN + TOTUM-63 
COMBINATION FOR POSSIBLE USE IN DIABETES REAL LIFE PRACTICE 
    * NO RISK OF HYPOGLYCEMIA FOR THE METFORMIN + TOTUM-63 
COMBINATION 
SHOWN IN PRECLINICAL STUDIES 
    * FIRST POSITIVE PRECLINICAL RESULTS ON INSULINEMIA, DURING 
AN 
ORAL GLUCOSE TOLERANCE TEST 
    * GOOD INITIAL RESULTS PAVE WAY FOR CLINICAL TRIAL IN TYPE 2 
DIABETIC PATIENTS TREATED WITH METFORMIN 
 
Source text for Eikon:  ID:nBw50043Ja  
Further company coverage:  ALVAL.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))